Studies explore factors that underlie varied responses to cancer drugs.
Hampton
Tracy
T
D000367:Age Factors; D000740:Anemia / Q000139:chemically induced / Q000188:drug therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D002908:Chronic Disease; D018450:Disease Progression; D018572:Disease-Free Survival; D004336:Drug Antagonism; D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D053614:Janus Kinase 2 / Q000378:metabolism; D009369:Neoplasms / Q000098:blood supply* / Q000401:mortality; D009389:Neovascularization, Pathologic / Q000139:chemically induced*; D019338:Polypharmacy; D012333:RNA, Messenger / Q000378:metabolism; D017467:Receptors, Erythropoietin / Q000378:metabolism
D000970:Antineoplastic Agents; D012333:RNA, Messenger; D017467:Receptors, Erythropoietin; D004921:Erythropoietin; D053614:Janus Kinase 2